On the contrary, established AML driver mutations JAK2V617F and P53M133K (P53 loss of function) were present at variant allele frequencies of 100% in all groups, as expected from their role as founding mutations in HEL cell line31 (Supplementary Fig. 8f). This evidence concerns the gene TP53 and acute myeloid leukemia.